We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : Oct 2023
  • Code : CMI4260
  • Pages :170
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

The Global Gelatin Sponge Market is estimated to be valued at US$ 235.9 million in 2023 and is expected to exhibit a CAGR of 6.4% during the forecast period (2023-2030).

Analysts’ Views on Global Gelatin Sponge Market:

A gelatin sponge is an absorbable medical dressing applied to the bleeding surface in order to provide hemostasis. The rising number of surgeries performed, such as minimally invasive surgery, general surgery, and others. Thus, it offers the opportunity for various manufacturers to offer gelatin sponges for application to bleeding surfaces as hemostatic.

Figure 1. Global Gelatin Sponge Market Share (%), By Origin, 2023

GELATIN SPONGE MARKET

To learn more about this report, request a free sample copy

Global Gelatin Sponge Market– Drivers

  • Increasing number of surgical procedures: The rising number of surgical procedures is expected to drive the growth of the gelatin sponge market over the forecast period. For instance, according to data provided by the World Cancer Research Fund International, in March 2022, there were an estimated 18.1 million cancer cases around the world in 2020. Of these, 9.3 million cases were in men and 8.8 million in women. Breast and lung cancers were the most common cancers worldwide, contributing 12.5% and 12.2% of the total number of new cases diagnosed in 2020.

Figure 2. Global Gelatin Sponge Market Share (%), By Region, 2023

GELATIN SPONGE MARKET

To learn more about this report, request a free sample copy

Global Gelatin Sponge Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global gelatin sponge market over the forecast period. This is attributed to the increasing prevalence of cardiovascular diseases in the U.S. For instance, on May 15, 2023, according to data provided by the Center of Disease Control and Prevention, heart disease was the leading cause of death among men, women, and people of most racial and ethnic groups in the U.S. One person dies every 33 seconds in the U.S. from cardiovascular disease. About 695,000 people in the U.S. died from heart disease in 2021.

Global Gelatin Sponge Market – Impact of Coronavirus (COVID-19) Pandemic

  • Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.
  • COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, the U.A.E., Egypt, and others, faced problems with the transportation of things from one place to another.
  • However, the COVID-19 pandemic had a negative impact on the global gelatin sponge market. For instance, in September 2021, according to the data published in the American Journal of Managed Care, chronic wound care had been delayed during the COVID-19 pandemic, which resulted in several infections and increased hospital admissions. As a result of delayed care during the COVID-19 pandemic, it will be crucial for clinicians, hospitals, and outpatient departments to comprehend and prepare for an increase in patients with untreated and uncontrolled non-healing wounds and concomitant acute-on-chronic problems. Also, some patients have avoided appointments at wound care clinics due to fear of exposure to COVID-19.

Gelatin Sponge Market Report Coverage

Report Coverage Details
Base Year: 2022 Market Size in 2023: US$ 235.9 Mn
Historical Data for: 2018 to 2022 Forecast Period: 2023 to 2030
Forecast Period 2023 to 2030 CAGR: 6.4% 2030 Value Projection: US$ 364.2 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Origin: Porcine, Bovine
  • By Application: Minimally Invasive Surgery, General Surgery, Neuro Surgery, Cardiovascular Surgery, Orthopedic Surgery, Others (ENT, Surgery, etc.)
  • By End User: Hospitals, Specialty Clinics, Others (Ambulatory Surgical Centers, etc.)
Companies covered:

Pfizer Inc., B. Braun SE, GELITA MEDICAL, CuraMedical B.V., Aegis Lifesciences, Angellifescience, EON Meditech, GOODWILL LIFESCIENCES PVT. LTD, Mil Laboratories Pvt. Ltd., EUCARE PHARMACEUTICALS (P) LTD., Medzeel Lifescience, Healthium Medtech Limited, Aegis Lifesciences, Omnia Health, and Advin Health Care

Growth Drivers:
  • Increasing number of surgical procedures 
Restraints & Challenges:
  • Increasing product recall by regulatory authorities

Global Gelatin Sponge Market Segmentation:

The global gelatin sponge market report is segmented into origin, application, end user and region.

  • Based on origin, the global gelatin sponge market is segmented into porcine and bovine. Out of which, porcine is expected to dominate the global gelatin sponge market during the forecast period, and this is due to the increasing use of porcine for development of gelatin sponge.
  • Based on application, the global gelatin sponge market is segmented into minimally invasive surgery, general surgery, neuro surgery, cardiovascular surgery, orthopedic surgery, and others (ENT surgery, etc.). Out of which, minimally invasive surgery segment is expected to dominate the market over the forecast period, and this is attributed to increasing number of minimally invasive surgery.
  • Based on end user, the global gelatin sponge market is segmented into hospitals, specialty clinics and others (ambulatory surgical centers, etc.) Out of which, the hospitals is expected to dominate the market over the forecast period, and this is attributed to the increasing usage of gelatin sponges in hospitals for a wide range of surgical applications.
  • Based on region, the global gelatin sponge market is segmented into North America, Latin America, Europe, Middle East, and Africa. Out of which, North America is expected to dominate the market over the forecast period, and this is due to the increasing number of surgeries in North America.
  • Among all the segmentation, the application segment is expected to dominate the market over the forecast period, and this is attributed to the increasing number of surgeries globally.

Global Gelatin Sponge Market- Cross Sectional Analysis:

Among application, minimally invasive surgery segment is dominant during the forecast period. For instance, according to the World Health Organization (WHO), in 2019, it was reported that around 235 million major surgeries are conducted every year across the globe.

Global Gelatin Sponge Market : Key Developments

In September 2020, Merit Medical Systems, a medical device company, announced that they had launched Torpedo gelatin foam, indicated for use in the embolization of hypervascular tumors. Torpedo provides physicians with preshaped gelatin foam loaded into a cartridge with an optional blunt stylet, removing the need for manual foam shaping and providing fast and easy attachment to the catheter for delivery.

Global Gelatin Sponge Market: Key Trends

  • Rising fire incidences: Treatments for burn injuries include intervention therapies and the use of products such as traditional and advanced care dressings. Rising fire incidences lead to an increasing demand for the treatment of burn injuries, especially in low- and middle-income countries. For instance, in August 2022, according to an article published by Springer Nature, 8,378,122 new cases (6,531,887-10,363,109 cases) of burns were identified worldwide in 2019, almost evenly split between males and females, and most new cases were 10 to 19 years old.

Global Gelatin Sponge Market: Restraint

  • Increasing product recalls by regulatory authorities: Factors such as product recalls and the presence of alternatives are expected to hinder the growth of the market. For instance, in October 2022, B. Braun SE, a medical device company, announced the product recall of Gelita-Tampon Absorbable Gelatin Sponge. This recall was due to an endotoxin concentration of the product that was measured to be above the limit in some samples during routine bioburden testing. The use of the affected products could potentially cause an acute pyrogenic reaction within two to five days after use. Factors such as product recall can hamper the growth of the market, but if the key market players in the market were focused on maintaining the quality of the product, then it could help reduce the product recall of the respective products.

Global Gelatin Sponge Market - Key Players

Major players operating in the global gelatin sponge market include Pfizer Inc., B. Braun SE, GELITA MEDICAL, CuraMedical B.V., Aegis Lifesciences, Angellifescience, EON Meditech, GOODWILL LIFESCIENCES PVT. LTD, Mil Laboratories Pvt. Ltd., EUCARE PHARMACEUTICALS (P) LTD., Medzeel Lifescience, Healthium Medtech Limited, Aegis Lifesciences, Omnia Health, and Advin Health Care.

Definition: Gelatin sponges are generally small, sterile, and surgical sponges that are used in surgical procedures as a hemostatic device. Each gelatin sponge is capable of absorbing and holding blood according to its mesh size. Gelatin sponges are prepared from specially treated and purified gelatin solutions. Gelatin sponge products are sterile and intended for single-use, as reuse can result in the transmission of HIV and hepatitis, which can endanger patients and health care providers. Gelatin sponges are mainly stored at 25 degrees but can extend storage temperature by 15 to 30 degrees.

Frequently Asked Questions

The global gelatin sponge market is estimated to be valued at US$ 235.9 million in 2023 and is expected to exhibit a CAGR of 6.4% between 2023 and 2030.

An increasing number of surgical procedures is expected to drive the market growth.

Minimally invasive surgery is the leading application segment in the market.

Increasing product recalls by regulatory authorities are expected to hinder the market over the forecast period.

Major players operating in the market are include Pfizer Inc., B. Braun SE, GELITA MEDICAL, CuraMedical B.V., Aegis Lifesciences, Angellifescience, EON Meditech, GOODWILL LIFESCIENCES PVT. LTD, Mil Laboratories Pvt. Ltd., EUCARE PHARMACEUTICALS (P) LTD., Medzeel Lifescience, Healthium Medtech Limited, Aegis Lifesciences, Omnia Health, and Advin Health Care

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Reliability and Reputation

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Reliability and Reputation

27001:2022

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo